Find and Pitch Jounalists, Get Your Story Covered

Tags: Dell XPS laptop laptop lineup Students student-success

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Seagen and Astellas announce results from EV-302 study - over 1 year ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer - 2 months ago New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors - 2 months ago FDA Approves Zanidatamab for Biliary Tract Cancer - 5 months ago Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets - 7 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 7 months ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - about 1 year ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - about 1 year ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - over 1 year ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - over 1 year ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - over 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - over 1 year ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Illuccix therapy gets approval in the UK - 2 months ago MHRA grants approval for bladder cancer drug erdafitinib - 5 months ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Grants Priory Review for Human Monoclonal Antibody Drug to Treat Muscle-Invasive Bladder Cancer - 4 months ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 5 months ago Utidelone Injectable Granted FDA Orphan Drug Designation for Breast Cancer Brain Metastasis - about 1 year ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - over 1 year ago
5	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 6 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 10 months ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - over 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - over 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - over 1 year ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure - 6 months ago
7	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 7 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 7 months ago FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 10 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - about 1 year ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - over 1 year ago
9	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - 10 months ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 11 months ago

Journalists covering locally advanced or metastatic urothelial carcinoma ,metastatic urothelial carcinoma,antibody drug conjugate ,nectin-4